Overview
Description
Twist Bioscience Corporation is a biotechnology company specializing in synthetic biology and genomics. Its core purpose is to industrialize DNA engineering through a proprietary platform that writes DNA on silicon, enabling high-throughput, precise, and cost-effective synthesis. The company supplies a broad portfolio spanning synthetic genes, oligonucleotide pools, next-generation sequencing preparation tools, variant and antibody libraries, synthetic controls, and IVDR-compliant products. These offerings underpin critical workflows in cancer research, infectious disease surveillance, drug discovery, and emerging areas such as DNA-based data storage. Twist Bioscience serves customers across healthcare, industrial chemicals, agriculture, and academic research, supporting discovery, development, and production applications. By scaling custom DNA manufacturing and related genomic tools, the company plays an important role in accelerating innovation for researchers and biotechnology developers globally. The organization is headquartered in South San Francisco and operates across multiple regions, reflecting its position as a key enabler in the synthetic biology supply chain and in antibody discovery infrastructure for biopharmaceutical R&D.
About
CEO
Dr. Emily Marine Leproust Ph.D.
Employees
979
Address
681 Gateway Boulevard
South San Francisco, 94080, CA
United States
South San Francisco, 94080, CA
United States
Phone
800 719 0671
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Diagnostics & Research
Country
Italy
MIC code
XMIL